KaydedilenlerDerginizi ekleyin

Dergiler / Laparoscopic Endoscopic Surgical Science / 2021 / Cilt: 28 - Sayı: 2

Post-ERCP complications, risk factors and management of complications

Umut Eren ERDOĞDU
Hacı Murat ÇAYCI
Ufuk ARSLAN
Ali TARDU
Yurdakul Deniz FIRAT
Müfit ŞANSAL
Gözde DOĞAN
Direnç YİĞİT
Sayfa
93–98
Yayın Tarihi
2022-09-04
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Understanding the risk factors and early diagnosis and treatment of complications are the waysto reduce morbidity and mortality in the management of post-ERCP complications.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional procedure usedfor the diagnosis and treatment of hepatopancreaticobiliary system diseases.
📊
Temel Bulgular & Veri:Materials and Methods: The study retrospectively reviewed 765 patients’ data of ERCP performed by thesame endoscopist for the diagnosis and treatment of hepatopancreaticobiliary diseases at a single centerbetween April 2019 and February 2021.
💡
Sonuç & Katkı:Conclusion: Understanding the risk factors and early diagnosis and treatment of complications are the waysto reduce morbidity and mortality in the management of post-ERCP complications.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional procedure usedfor the diagnosis and treatment of hepatopancreaticobiliary system diseases. The aim of this study is toevaluate post-ERCP complications, risk factors, and management of complications of ERCP proceduresperformed in the endoscopy unit of our hospital. Materials and Methods: The study retrospectively reviewed 765 patients’ data of ERCP performed by thesame endoscopist for the diagnosis and treatment of hepatopancreaticobiliary diseases at a single centerbetween April 2019 and February 2021. Interventional procedures were reviewed in terms of ERCP indications,procedure-related complications, risk factors for complications, and management of the complications. Results: A total of 765 procedures were carried out. The successful cannulation rate was 91.9%. The mostcommon indicators for the ERCP procedure were choledocholithiasis (43.6%), high levels of cholestasis bio markers/intra-extrahepatic bile duct dilatation (19%) ve removal of bile duct stents (12.5%). The most com mon risk factors were; female gender (60.9%) and younger age (42.3%) for post-ERCP pancreatitis, pre-cut(10.9%) and anticoagulant therapy (7.5%) for bleeding, papillary abnormalities (22.4%) for perforation, andolder age (42.8%) for cholangitis. The most common complications were hyperamylasemia and pancreatitis(17.2%), bleeding (2%), cholangitis (1.83), and perforation (0.65%). Mortality occurred in 0.26% of patientsdue to post-ERCP cholangitis. Conclusion: Understanding the risk factors and early diagnosis and treatment of complications are the waysto reduce morbidity and mortality in the management of post-ERCP complications.

🔖

Bu Makaleye Atıf Yap

ERDOĞDU, U. E., ÇAYCI, H. M., ARSLAN, U., TARDU, A., FIRAT, Y. D., ŞANSAL, M., DOĞAN, G., YİĞİT, D. (2022). Post-ERCP complications, risk factors and management of complications. Laparoscopic Endoscopic Surgical Science, Cilt: 28 - Sayı: 2, 93–98. https://ajindex.com/articles/423554

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y) 2013;9:496–504
  2. Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781–8
  3. Tarnasky PR, Kedia P. Endoscopic retrograde cholangiopancreatography complications: Techniques to reduce risk and management strategies. Gastrointest Interv 2017;6:37–53
  4. Barthet M, Lesavre N, Desjeux A, Gasmi M, Berthezene P, Berdah S, et al. Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 2002;34:991–7
  5. Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60:721–31
  6. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, Ben-Menachem T, et al. Complications of ERCP. Gastrointest Endosc 2012;75:467–73
  7. Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, et al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol 2014;49:752–8
  8. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–11
  9. Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2020;52:127–49
  10. Shah AP, Mourad MM, Bramhall SR. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res 2018;11:77–85
  11. Cotton PB, Eisen GM, Aabakken L, Baron T H, Hutter MM, Jacobson BC, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446–54
  12. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, Chandrasekhara V, Chathadi KV, Early DS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016;83:3–16
  13. Lin WC, Lin HH, Hung CY, Shih SC, Chu CH. Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding. PloS One 2017;12:e0177449
  14. Williams, Taylor S, Fairclough P, Hamlyn A, Logan RF, Martin D, et al. Risk factors f